Rituximab is a drug used to treat rheumatoid arthritis and B-cell non-Hodgkin's lymphoma. This drug is given intravenously and comes under the group of medications called monoclonal antibodies.
Rituximab and Hyaluronidase Human Injection - A New Treatment for Follicular Lymphoma
Rituximab and Hyaluronidase human is a new subcutaneous formulation of Rituximab for the treatment of adult patients with follicular lymphoma.
Rituximab: Current and Future scope
Rituximab is a monoclonal antibody drug used against various cancers and autoimmune conditions like pemphigus and non-Hodgkin lymphoma.